Back to Posters

Validation of patient-facing digital tool risk stratification of those at risk for hereditary cancer syndrome: The CARE program accurately identifies high risk individuals

Date:
Thursday, Oct 19, 2023 4:30pm – 6:30pm
Conference:
NSGC 2023
Authors:
Carrie Horton, Carrie Milliard, Deepika Nathan, Devon Lamb Thrush, Haley Keller, Heather Fecteau, Lukas Lyon, Robert Pilarski, Sarah Siddiqui, Shannon Kieran

Take home points:

  1. The purpose of this study was to assess the analytic validity for the CARE platform by determining the accuracy of the digital tool’s execution and interpretation of NCCN guidelines® as compared to certified genetic counselor’s (CGC) interpretation of the same guidelines.
  2. The CARE program’s analytic validity was 99.5% (398/400) for identifying individuals who met NCCN® genetic testing criteria.
  3. The CARE program accurately identifies individuals who meet NCCN® testing criteria to aid in risk stratification.
Poster Abstract